The BECN1 N-terminal domain is intrinsically disordered
Erinna F Lee1,2,3,4,5, Matthew A Perugini6, Anne Pettikiriarachchi1
1a The Walter and Eliza Hall Institute of Medical Research , Parkville , Victoria , Australia.
Autophagy
|April 6, 2016
Summary
The N-terminal domain of Beclin 1 (BECN1) is intrinsically disordered. It remains disordered upon binding BCL2L1, except for the BH3 subdomain, revealing key structural insights into autophagy regulation.
Area of Science:
- Molecular Biology
- Structural Biology
- Cell Biology
Background:
- Beclin 1 (BECN1) is crucial for initiating autophagosome formation.
- Previous structural studies focused on BECN1's central and C-terminal domains.
- The N-terminal domain of BECN1 remained structurally uncharacterized due to production challenges.
Purpose of the Study:
- To express and purify the N-terminal domain of BECN1 (residues 1-150).
- To perform detailed biophysical characterization, including NMR spectroscopy.
- To elucidate the structural behavior of the BECN1 N-terminal domain and its interaction with BCL2L1.
Main Methods:
- Protein expression and purification of BECN1 N-terminal domain (residues 1-150).
- Nuclear Magnetic Resonance (NMR) spectroscopy for biophysical characterization.
- Analysis of BECN1 N-terminal domain interaction with BCL2L1 and competitive inhibitors.
Main Results:
- The BECN1 N-terminal domain (residues 1-150) was successfully expressed and purified.
- NMR studies revealed the BECN1 N-terminal domain is intrinsically disordered.
- Upon binding BCL2L1, the BECN1 N-terminal domain remains disordered, except for the BH3 subdomain, which forms an alpha-helix that reverts to disorder upon inhibitor-induced dissociation.
Conclusions:
- The N-terminal domain of BECN1 is predominantly intrinsically disordered.
- Binding to BCL2L1 induces a transient helical structure in the BH3 subdomain.
- No significant interactions were observed between the N- and C-terminal domains of BECN1.
Keywords:
BCL2BECN1BH3 domainBeclin 1autophagyintrinsically disordered protein; nuclear magnetic resonanceMore Related Videos
Related Concept Videos
Amyloid Fibrils
12.8K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
12.8K
Intrinsically Disordered Proteins
21.4K
Intrinsically disordered proteins are a group of proteins that do not fold into specific three-dimensional structures. Their structural flexibility allows them to complement ordered proteins to perform functions that are inaccessible to rigid structures. They are more common in eukaryotes than prokaryotes and may either be exclusively intrinsically disordered or hybrid proteins, consisting of a mix of ordered and disordered regions. The absence of a rigid structure in these proteins can be...
21.4K
Intrinsically Disordered Proteins
3.0K
3.0K
ATP Synthase: Mechanism
18.5K
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
18.5K
Allosteric Proteins-ATCase
6.9K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
6.9K
Inborn Errors of Metabolism
997
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
997


